Literature DB >> 28621151

Case report and literature review on contrast-induced encephalopathy.

Mardi Hamra1, Yasir Bakhit2, Mahboob Khan3, Roger Moore4.   

Abstract

Contrast-induced encephalopathy (CIE) is a rare neurological complication following the administration of injectable intravascular contrast media. Patients with CIE present a wide spectrum of symptoms such as headache, transient cortical blindness, seizure and focal neurological deficits. The diagnosis of CIE requires a high index of suspicion. Its early recognition is of paramount importance in instituting the appropriate supportive treatment in the form of intravenous fluids and also in avoiding unnecessary potentially harmful treatment such as intravenous thrombolysis for suspected ischemic stroke. Here, we report the case of a 62-year-old male patient with a typical presentation of CIE immediately following coronary angiography. We then continue to briefly review the relevant literature on CIE to date.

Entities:  

Keywords:  cardiac catheterization; contrast neuropathy; contrast-induced encephalopathy; coronary angiography; stroke

Mesh:

Substances:

Year:  2017        PMID: 28621151     DOI: 10.2217/fca-2016-0075

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  3 in total

Review 1.  Case Report and Literature Review on Low-Osmolar, Non-Ionic Iodine-Based Contrast-Induced Encephalopathy.

Authors:  Meng-Ru Liu; Hong Jiang; Xian-Lun Li; Peng Yang
Journal:  Clin Interv Aging       Date:  2020-12-04       Impact factor: 4.458

2.  Contrast-Induced Encephalopathy after Cerebral Angiogram: A Case Series and Review of Literature.

Authors:  Cecelia Allison; Vaibhav Sharma; Jason Park; Clemens M Schirmer; Ramin Zand
Journal:  Case Rep Neurol       Date:  2021-06-18

3.  Contrast-induced encephalopathy and permanent neurological deficit: A case report and literature review.

Authors:  Paola Maria Francesca Cristaldi; Alessandra Polistena; Mirko Patassini; Camilla de Laurentis; Carlo Giussani; Paolo Remida
Journal:  Surg Neurol Int       Date:  2021-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.